SEC Form 13F
| Report period | 2026-06-30 |
|---|---|
| Publicly available | 2026-08-15 |
| Reported value | $8,173,736,250 |
| Positions | 333 |
| Issuer | Ticker | Class | Reported value | Reported amount |
|---|---|---|---|---|
| STATE STR SPDR S&P 500 ETF T | SPY | TR UNIT | $2,389,664,000 | 3,200,000 |
| ISHARES TR | IWM | RUSSELL 2000 ETF | $1,742,610,000 | 5,800,000 |
| MADRIGAL PHARMACEUTICALS INC | MDGL | COM | $154,641,600 | 288,000 |
| CYTOKINETICS INC | CYTK | COM NEW | $130,340,700 | 1,530,000 |
| SUPERNUS PHARMACEUTICALS | SUPN | COM | $123,074,809 | 2,646,201 |
| AGIOS PHARMACEUTICALS INC | AGIO | COM | $104,279,100 | 2,810,000 |
| CYTOKINETICS INC | CYTK | COM NEW | $102,342,325 | 1,201,342 |
| INCYTE CORP | INCY | COM | $102,024,567 | 900,005 |
| NEUROCRINE BIOSCIENCES INC | NBIX | COM | $90,307,457 | 535,838 |
| TRAVERE THERAPEUTICS INC | TVTX | COM | $89,335,941 | 1,572,539 |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.